Skip to main content

Table 1 Baseline characteristics of patients in the two groups

From: Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma

CharacteristicIMRT group (n = 62)IMRT/chemotherapy group (n = 62)P
Age  0.055
 ≤ 45 years15 (24.2%)25 (40.3%) 
 > 45 years47 (75.8%)37 (59.7%) 
Sex  1.000
 Male44 (71.0%)44 (71.0%) 
 Female18 (29.0%)18 (29.0%) 
Histology  0.144
 WHO type II2 (3.2%)6 (9.7%) 
 WHO type III60 (96.8%)56 (90.3%) 
T category  0.431
 T114 (22.6%)18 (29.0%) 
 T241 (66.1%)34 (54.8%) 
 T37 (11.3%)10 (16.1%) 
N category  0.701
 N021 (33.9%)19 (30.6%) 
 N141 (66.1%)43 (69.4%) 
TNM stage  0.433
 II55 (88.7%)52 (83.9%) 
 III (T3N0M0)7 (11.3%)10 (16.1%) 
  1. All data are n (%)
  2. IMRT Intensity-modulated radiotherapy, WHO World Health Organization